Table of Content


Chapter 1. Global Non-Small Cell Lung Cancer Market Executive Summary
1.1. Global NSCLC Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Treatment
1.3.3. By Distribution Channel
1.4. Key Trends
1.5. COVID-19 Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global NSCLC Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Manufacturing Capacity
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Competitive Landscape
2.3.3.5. Economic Viability (Payer Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Reimbursement Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Patient Awareness & Access
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global NSCLC Market Dynamics
3.1. Market Drivers
3.1.1. Rising Incidence of Lung Cancer & Early Diagnosis
3.1.2. Adoption of Immuno-Oncology Agents
3.1.3. Growth of Precision Medicine & Companion Diagnostics
3.2. Market Challenges
3.2.1. Therapeutic Resistance (EGFR, ALK Mutations)
3.2.2. High Treatment Costs & Access Disparities
3.3. Market Opportunities
3.3.1. Combination Regimens (Chemo + Immunotherapy)
3.3.2. AI-Driven Clinical Research & Real-World Evidence
3.3.3. Expansion in Emerging Oncology Markets
Chapter 4. Global NSCLC Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Future Outlook of Five Forces
4.1.7. Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global NSCLC Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. NSCLC Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Squamous Cell Carcinoma
5.2.2. Large Cell Carcinoma
Chapter 6. Global NSCLC Market Size & Forecasts by Treatment 2022-2032
6.1. Segment Dashboard
6.2. NSCLC Market: Treatment Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Chemotherapy
6.2.2. Immunotherapy
Chapter 7. Global NSCLC Market Size & Forecasts by Distribution Channel 2022-2032
7.1. Segment Dashboard
7.2. NSCLC Market: Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospital Pharmacy
7.2.2. Retail Pharmacy
7.2.3. Online Pharmacy
7.2.4. Others
Chapter 8. Global NSCLC Market Size & Forecasts by Region 2022-2032
8.1. North America NSCLC Market
8.1.1. U.S. NSCLC Market
8.1.1.1. Type Breakdown & Forecasts, 2022-2032
8.1.1.2. Treatment Breakdown & Forecasts, 2022-2032
8.1.2. Canada NSCLC Market
8.2. Europe NSCLC Market
8.2.1. UK NSCLC Market
8.2.2. Germany NSCLC Market
8.2.3. France NSCLC Market
8.2.4. Spain NSCLC Market
8.2.5. Italy NSCLC Market
8.2.6. Rest of Europe NSCLC Market
8.3. Asia Pacific NSCLC Market
8.3.1. China NSCLC Market
8.3.2. India NSCLC Market
8.3.3. Japan NSCLC Market
8.3.4. Australia NSCLC Market
8.3.5. South Korea NSCLC Market
8.3.6. Rest of Asia Pacific NSCLC Market
8.4. Latin America NSCLC Market
8.4.1. Brazil NSCLC Market
8.4.2. Mexico NSCLC Market
8.4.3. Rest of Latin America NSCLC Market
8.5. Middle East & Africa NSCLC Market
8.5.1. Saudi Arabia NSCLC Market
8.5.2. South Africa NSCLC Market
8.5.3. Rest of Middle East & Africa NSCLC Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Merck & Co., Inc.
9.1.2. AstraZeneca plc
9.1.3. Bristol-Myers Squibb Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Merck & Co., Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. AstraZeneca plc
9.3.3. Bristol-Myers Squibb Company
9.3.4. Hoffmann-La Roche Ltd.
9.3.5. Pfizer Inc.
9.3.6. Novartis AG
9.3.7. Sanofi S.A.
9.3.8. Eli Lilly and Company
9.3.9. Amgen Inc.
9.3.10. Takeda Pharmaceutical Company Limited



List of Figures

List of Figures
FIG 1. Global NSCLC market, research methodology
FIG 2. Global NSCLC market, market estimation techniques
FIG 3. Global NSCLC market size estimates & forecast methods
FIG 4. Global NSCLC market, key trends 2023
FIG 5. Global NSCLC market, growth prospects 2022-2032
FIG 6. Global NSCLC market, Porter’s five forces model
FIG 7. Global NSCLC market, PESTEL analysis
FIG 8. Global NSCLC market, value chain analysis
FIG 9. NSCLC market by Type, 2022 & 2032 (USD Billion)
FIG 10. NSCLC market by Treatment, 2022 & 2032 (USD Billion)
FIG 11. NSCLC market by Distribution Channel, 2022 & 2032 (USD Billion)
FIG 12. North America NSCLC market, 2022 & 2032 (USD Billion)
FIG 13. Europe NSCLC market, 2022 & 2032 (USD Billion)
FIG 14. Asia Pacific NSCLC market, 2022 & 2032 (USD Billion)
FIG 15. Latin America NSCLC market, 2022 & 2032 (USD Billion)
FIG 16. Middle East & Africa NSCLC market, 2022 & 2032 (USD Billion)
FIG 17. Global NSCLC market, company market share analysis (2023)
FIG 18. Global NSCLC market, R&D investment trends
FIG 19. Global NSCLC market, pricing analysis by region
FIG 20. Global NSCLC market, patient journey mapping
This Table of Contents is subject to change based on the final report structure.

List of Tables

List of Tables
TABLE 1. Global NSCLC market, report scope
TABLE 2. Global NSCLC market estimates & forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global NSCLC market estimates & forecasts by Type 2022-2032 (USD Billion)
TABLE 4. Global NSCLC market estimates & forecasts by Treatment 2022-2032 (USD Billion)
TABLE 5. Global NSCLC market estimates & forecasts by Distribution Channel 2022-2032 (USD Billion)
TABLE 6. Global NSCLC market by segment, estimates & forecasts, 2022-2032 (USD Billion)
TABLE 7. North America NSCLC market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 8. Europe NSCLC market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 9. Asia Pacific NSCLC market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 10. Latin America NSCLC market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 11. Middle East & Africa NSCLC market estimates & forecasts, 2022-2032 (USD Billion)
TABLE 12. U.S. NSCLC market estimates & forecasts by Type, 2022-2032 (USD Billion)
TABLE 13. U.S. NSCLC market estimates & forecasts by Treatment, 2022-2032 (USD Billion)
TABLE 14. Europe NSCLC market estimates & forecasts by Country, 2022-2032 (USD Billion)
TABLE 15. Asia Pacific NSCLC market estimates & forecasts by Country, 2022-2032 (USD Billion)
TABLE 16. Latin America NSCLC market estimates & forecasts by Country, 2022-2032 (USD Billion)
TABLE 17. Middle East & Africa NSCLC market estimates & forecasts by Country, 2022-2032 (USD Billion)
TABLE 18. Global NSCLC market competitive landscape (2023)
TABLE 19. Global NSCLC market patent filings & approvals by year
TABLE 20. Key clinical trial pipeline for NSCLC therapies